Evidence map›Paper›PMID 22419341›Full record

SynthesisThe Cochrane database of systematic reviews2012

Antibiotics prior to embryo transfer in ART.

Ben Kroon, Roger J Hart, Brittany M S Wong, Emily Ford, Anusch Yazdani

Registry-linked trialAbstract readSystematic Review
PubMed Publisher
In one paragraph

Synthesis in The Cochrane database of systematic reviews, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03386227 (Prophylactic Antibiotics Prior to Embryo Transfer), which is not on this map. Cited by 19 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 4 pooled it
3.4field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03386227 naterminatednot on this mapstarted 2018, after this paper: background citation

Prophylactic Antibiotics Prior to Embryo Transfer: a Randomized Controlled Trial

TypeinterventionalSponsorWashington University School of MedicineRan2018 to 2019Enrolled96ConditionsAssisted Reproductive Technology, Antibiotic Prophylaxis, Embryo TransferArmsWithholding antibiotic prophylaxis
3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 4 syntheses or guidelines pooled it, 57 citations in OpenAlex.

  1. Antibiotics prior to or at the time of embryo transfer in ART.The Cochrane database of systematic reviews · 2023
    Pooled it
  2. Assisted reproductive technology: an overview of Cochrane Reviews.The Cochrane database of systematic reviews · 2018
    Pooled it
  3. Pooled it
  4. Prophylactic antibiotics for transcervical intrauterine procedures.The Cochrane database of systematic reviews · 2013
    Pooled it
  5. Trial
  6. Trial
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Review
  17. Comprehensive evidence on assisted reproductive technologies.The Cochrane database of systematic reviews · 2014
    Article
  18. Article
  19. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Ben KroonUniversity of Queensland, Queensland Fertility Group Research Foundation, Brisbane, Australia.benkroon1@gmail.com.
Roger J Hart
Brittany M S Wong
Emily Ford
Anusch Yazdani
University of Queensland · AUUniversity of Western Australia · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundEmbryo transfer (ET) involves the placement of one or more embryos into the uterine cavity, usually by passing a catheter through the cervical os. ET is the final step in an assisted reproductive technology (ART) cycle, where a woman has undergone controlled ovarian stimulation, egg retrieval and in vitro fertilisation of her eggs. Despite the transfer of high quality embryos, many ETs do not result in a pregnancy. There are many factors which may affect the success of ET, including the presence of upper genital tract microbial colonisation. The administration of antibiotics prior to ET has been suggested as an intervention to reduce levels of microbial colonisation and hence improve pregnancy rates.

objectivesTo evaluate the effectiveness and safety of antibiotic administration prior to ET during ART cycles. SEARCH

methodsWe searched the Menstrual Disorders and Subfertility Group Specialised Register, Cochrane Central Register of Controlled Trials (CENTRAL), The Cochrane Library, MEDLINE, Ovid MEDLINE® In-Process & Other Non-Indexed Citations, Ovid MEDLINE® Daily and Ovid MEDLINE® (from inception to February 2011), Ovid EMBASE (January 2010 to February 2011), Ovid PsycINFO, CINAHL, LILACS, trial registers for ongoing and registered trials, citation indexes, ClinicalStudyResults, PubMed, OpenSIGLE database and for for herbal and complimentary therapy protocols and reviews. SELECTION CRITERIA: Only randomised controlled trials were included. DATA COLLECTION AND ANALYSIS: The titles and abstracts of articles identified by the search were screened by one review author for eligibility. Two review authors then independently examined the full text articles for suitability for inclusion in the review. Data were extracted independently by two review authors. MAIN

resultsWe identified four potential studies, of which three were excluded.The included trial reported clinical pregnancy rates but not live births. There was no evidence of a difference in clinical pregnancy rate between those receiving an amoxycillin and clavulanic acid antibiotic combination (64/178: 36%) and those not (61/172: 35.5%) (OR1.02, 95% CI 0.66 to 1.58). Genital tract colonisation was significantly reduced in women receiving this antibiotic regimen (OR 0.59, 95% CI 0.37 to 0.95). AUTHORS'

conclusionsThis review suggests that the administration of amoxycillin and clavulanic acid prior to embryo transfer reduced upper genital tract microbial contamination but did not alter clinical pregnancy rates. The effect of this intervention on live birth is unknown. There are no data from randomised controlled trials to support or refute other antibiotic regimens in this setting.Future research is warranted to assess the efficacy of alternative antibiotic regimens. Researchers should assess live birth as the primary outcome and address quantitative microbial colonization as a secondary outcome.

Indexed as

Amoxicillin-Potassium Clavulanate CombinationAnti-Bacterial AgentsAntibiotic ProphylaxisEmbryo TransferFemaleHumansPregnancyPregnancy RateAmoxicillin-Potassium Clavulanate CombinationAnti-Bacterial Agents

Identifiers

PMID22419341
OpenAlexW1584680572

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.